4th Year of Pharm D (Written)
₨ 3,000
₨ 2,500
Curriculum
- 5 Sections
- 76 Lessons
- 365 Days
Expand all sectionsCollapse all sections
- PHARMACY PRACTICE-III (HOSPITAL PHARMACY)22
- 1.1INTRODUCTION OF HOSPITAL PHARMACY CH # 01
- 1.2HOSPITAL AND ITS ORGANIZATION CH # 02
- 1.3PHARMACY, ITS ORGANIZATION CH # 03
- 1.4PHARMACY AND THERAPEUTIC COMMITTEE CH # 04
- 1.5THE HOSPITAL FORMULARY CH # 05
- 1.6DISPENSING TO IN-PATIENTS CH # 06
- 1.7DISPENSING TO AMBULATORY PATIENTS CH # 07
- 1.8DISTRIBUTION OF CONTROL SUBSTANCES CH # 08
- 1.9DISPENSING DURING OFF-HOURS CH # 09
- 1.10SAFE USE OF MEDICATION IN THE HOSPITAL CH # 10
- 1.11MANUFACTURING BULK AND STERILE CH # 11
- 1.12THE PHARMACY; CENTRAL STERILE SUPPLY ROOM CH # 12
- 1.13ASEPTIC DISPENSING CH # 13
- 1.14ROLE OF PHARMACIST IN SMALL HOSPITALS CH # 14
- 1.15PURCHASING, DISTRIBUTION, CONTROL CH # 15
- 1.16NUCLEAR PHARMACY CH # 16
- 1.17THE PHYSICAL PLANT AND ITS EQUIPMENT CH # 17
- 1.18INVESTIGATIONAL USE OF DRUGS CH # 18
- 1.19HEALTH ACCESSORIES CH # 19
- 1.20SURGICAL SUPPLIES CH # 20
- 1.21INSPECTION OF WARDS CH # 21
- 1.22MANAGEMENT EMERGENCY PHARMACY (A & E) CH # 22
- PHARMACY PRACTICE-IV (CLINICAL PHARMACY-I)12
- 2.1GENERAL INTRODUCTION TO CLINICAL PHARMACY CH # 01
- 2.2DISEASE MANAGEMENT CH # 02
- 2.3PATIENT PROFILE & PATIENT COUNSELING CH # 03
- 2.4CLINICAL TRIALS OF DRUG SUBSTANCES CH # 04
- 2.5EMERGENCY TREATMENT CH # 05
- 2.6DRUG INTERACTIONS CH # 06
- 2.7PHARMACOVIGILANCE CH # 07
- 2.8PHARMACOTHERAPY PLAN CH # 08
- 2.9DRUG INDUCED DISEASES CH # 09
- 2.10UTILIZATION OF CLINICAL DRUG LITERATURE CH # 10
- 2.11ONLINE PHARMACEUTICAL CARE SERVICES AND GLOBALIZATION CH # 11
- 2.12PROVISION OF PHARMACEUTICAL CARE IN MULTIPLE ENVIRONMENTS CH # 12
- PHARMACEUTICS-IV (INDUSTRIAL PHARMACY)16
- 3.1MASS TRANSFER CH # 01
- 3.2HEAT TRANSFER CH # 02
- 3.3DRYING CH # 03
- 3.4COMMINUTION (SIZE REDUCTION) CH # 04
- 3.5MIXING CH # 05
- 3.6CLARIFICATION AND FILTRATION CH # 06
- 3.7EVAPORATION CH # 07
- 3.8COMPRESSION AND COMPACTION CH # 08
- 3.9SAFETY METHODS IN PHARMACEUTICAL INDUSTRY CH # 09
- 3.10EMULSIONS CH # 10
- 3.11SUSPENSIONS CH # 11
- 3.12SEMISOLIDS CH # 12
- 3.13STERILE PRODUCTS CH # 13
- 3.14PACKING & PACKAGING CH # 14
- 3.15EQUIPMENTS USED CH # 15
- 3.16STUDY TOUR (PC-IV)
- PHARMACEUTICS-V (BIOPHARMACEUTICS &PHARAMCOKINETICS)14
- 4.1DEFINITIONS AND TERMINOLOGY CH # 01
- 4.2GASTRO-INTESTINAL ABSORPTION CH # 02
- 4.3BIOLOGICAL t1/2, Vd CH # 03
- 4.4DRUG CLEARANCE CH # 04
- 4.5PHARMACOKINETICS CH # 05
- 4.6BIOAVAILABILITY AND BIOEQUIVALENCE CH # 06
- 4.7CONCEPT OF COMPARTMENT(S) MODELS CH # 07
- 4.8MULTIPLE DOSAGE REGIMENS CH # 08
- 4.9ELIMINATION OF DRUGS CH # 09
- 4.10PROTEIN BINDING CH # 10
- 4.11PHARMACOKINETICS VARIATIONS IN DISEASE CH # 11
- 4.12PHARMACOKINETICS OF INTRAVENOUS INFUSIONS CH # 12
- 4.13BIOPHARMACEUTICAL ASPECTS IN DOSAGE FORM CH # 13
- 4.14IN-VITRO-IN-VIVO CORRELATION (IVIVC) CH # 14
- PHARMACEUTICS-VI (PHARMACEUTICAL QUALITY MANAGEMENT)12
- 5.1INTRODUCTION CH # 01
- 5.2QUALITY CONTROL OF SOLID DOSAGE FORMS CH # 02
- 5.3QUALITY CONTROL OF SYRUPS, ELIXIRS CH # 03
- 5.4QUALITY CONTROL OF SUPPOSITORIES CH # 04
- 5.5QUALITY CONTROL OF STERILE PRODUCTS CH # 05
- 5.6BIOLOGICAL ASSAYS CH # 06
- 5.7ALCOHOL DETERMINATION CH # 07
- 5.8ALKALOIDAL DRUG ASSAY CH # 08
- 5.9QUALITY ASSURANCE OF VACCINES CH # 09
- 5.10MISCELLANEOUS DETERMINATIONS AND TESTS CH # 10
- 5.11STANDARDIZATION OF PHARMACEUTICALS CH # 11
- 5.12STATISTICAL INTERPRETATION OF QC CHARTS CH # 12